{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:50:00Z","timestamp":1791903000890,"version":"4.3.4"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2002,6,1]],"date-time":"2002-06-01T00:00:00Z","timestamp":1022889600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr. Treat. Options in Oncol."],"published-print":{"date-parts":[[2002,6]]},"DOI":"10.1007\/s11864-002-0014-3","type":"journal-article","created":{"date-parts":[[2007,6,28]],"date-time":"2007-06-28T08:42:22Z","timestamp":1183020142000},"page":"247-254","source":"Crossref","is-referenced-by-count":24,"title":["Heavy chain disease"],"prefix":"10.1007","volume":"3","author":[{"given":"Thomas E.","family":"Witzig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dietlind L. Wahner-","family":"Roedler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,12,28]]},"reference":[{"key":"14_CR1","volume-title":"Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues.","author":"E Jaffe","year":"2001","unstructured":"Jaffe E, Harris N, Stein H, Vardiman J: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Edited by Kleihues P, Sobin L. Lyon, France: IARC Press; 2001."},{"key":"14_CR2","first-page":"1139","volume":"94","author":"KD Fine","year":"1999","unstructured":"Fine KD, Stone MJ: Alpha-heavy chain disease, Mediterranean lymphoma, and immunoproliferative small intestinal disease: a review of clinicopathological features, pathogenesis, and differential diagnosis. Am J Gastroenterol 1999, 94:1139\u20131152.","journal-title":"Am J Gastroenterol"},{"key":"14_CR3","first-page":"317","volume":"43","author":"M Seligmann","year":"1993","unstructured":"Seligmann M: [Heavy chain diseases]. Rev Prat 1993, 43:317\u2013320.","journal-title":"Rev Prat"},{"key":"14_CR4","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/978-3-642-81246-0_32","volume":"64","author":"JC Rambaud","year":"1978","unstructured":"Rambaud JC, Galian A, Matuchansky C, et al.: Natural history of alpha-chain disease and the so-called Mediterranean lymphoma. Recent Results Cancer Res 1978, 64:271\u2013276.","journal-title":"Recent Results Cancer Res"},{"key":"14_CR5","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1136\/gut.19.7.627","volume":"19","author":"Z Al-Bahrani","year":"1978","unstructured":"Al-Bahrani Z, Al-Saleem T, Al-Mondhiry H, et al.: Alpha heavy chain disease (report of 18 cases from Iraq). Gut 1978, 19:627\u2013631.","journal-title":"Gut"},{"key":"14_CR6","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00197509","volume":"12","author":"JC Rambaud","year":"1990","unstructured":"Rambaud JC, Halphen M, Galian A, Tsapis A: Immunoproliferative small intestinal disease (IPSID): relationships with alpha-chain disease and \"Mediterranean\" lymphomas. Springer Semin Immunopathol 1990, 12:239\u2013250.","journal-title":"Springer Semin Immunopathol"},{"key":"14_CR7","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1073\/pnas.95.5.2463","volume":"95","author":"T Goossens","year":"1998","unstructured":"Goossens T, Klein U, Kuppers R: Frequent occurrence of deletions and duplications during somatic hypermutation: implications for oncogene translocations and heavy chain disease. Proc Natl Acad Sci U S A 1998, 95:2463\u20132468.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"14_CR8","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1093\/clinchem\/40.4.664","volume":"40","author":"T Sun","year":"1994","unstructured":"Sun T, Peng S, Narurkar L, et al.: Modified immunoselection technique for definitive diagnosis of heavychain disease. Clin Chem 1994, 40:664.","journal-title":"Clin Chem"},{"key":"14_CR9","first-page":"472","volume":"9","author":"M Harzic","year":"1985","unstructured":"Harzic M, Girard-Pipau F, Halphen M, et al.: [Bacteriological, parasitological and virological study of the digestive flora in alpha-chain disease]. Gastroenterol Clin Biol 1985, 9:472\u2013479.","journal-title":"Gastroenterol Clin Biol"},{"key":"14_CR10","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/S0889-8588(05)70127-1","volume":"13","author":"JP Fermand","year":"1999","unstructured":"Fermand JP, Brouet JC: Heavy-chain diseases. Hematol Oncol Clin North Am 1999, 13:1281\u20131294.","journal-title":"Hematol Oncol Clin North Am"},{"key":"14_CR11","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/S0190-9622(08)80110-7","volume":"23","author":"K Lassoued","year":"1990","unstructured":"Lassoued K, Picard C, Danon F, et al.: Cutaneous manifestations associated with gamma heavy chain disease: report of an unusual case and review of literature. J Am Acad Dermatol 1990, 23:988\u2013991.","journal-title":"J Am Acad Dermatol"},{"key":"14_CR12","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/00002281-200001000-00011","volume":"12","author":"G Husby","year":"2000","unstructured":"Husby G: Is there a pathogenic link between gamma heavy chain disease and chronic arthritis? Curr Opin Rheumatol 2000, 12:65\u201370.","journal-title":"Curr Opin Rheumatol"},{"key":"14_CR13","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/ajcp\/78.4.427","volume":"78","author":"SM Wester","year":"1982","unstructured":"Wester SM, Banks PM, Li CY: The histopathology of gamma heavy-chain disease. Am J Clin Pathol 1982, 78:427\u2013436.","journal-title":"Am J Clin Pathol"},{"key":"14_CR14","first-page":"439","volume":"56","author":"RA Kyle","year":"1981","unstructured":"Kyle RA, Greipp PR, Banks PM: The diverse picture of gamma heavy-chain disease: report of seven cases and review of literature. Mayo Clin Proc 1981, 56:439\u2013451.","journal-title":"Mayo Clin Proc"},{"key":"14_CR15","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1365-2141.1994.tb05094.x","volume":"88","author":"S Agrawal","year":"1994","unstructured":"Agrawal S, Abboudi Z, Matutes E, Catovsky D: First report of fludarabine in gamma-heavy chain disease. Br J Haematol 1994, 88:653\u2013655.","journal-title":"Br J Haematol"},{"key":"14_CR16","first-page":"893","volume":"110","author":"S Otto","year":"1986","unstructured":"Otto S, Peter I, Vegh S, Juhos E, Besznyak I: Gammachain heavy-chain disease with primary thyroid plasmacytoma. Arch Pathol Lab Med 1986, 110:893\u2013896.","journal-title":"Arch Pathol Lab Med"},{"key":"14_CR17","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1600-0609.1995.tb00220.x","volume":"54","author":"LM Galanti","year":"1995","unstructured":"Galanti LM, Doyen C, Vander Maelen C, et al.: Biological diagnosis of a gamma-1-heavy chain disease in an asymptomatic patient. Eur J Haematol 1995, 54:202\u2013204.","journal-title":"Eur J Haematol"},{"key":"14_CR18","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/ajh.2830400112","volume":"40","author":"DL Wahner-Roedler","year":"1992","unstructured":"Wahner-Roedler DL, Kyle RA: Mu-heavy chain disease: presentation as a benign monoclonal gammopathy. Am J Hematol 1992, 40:56\u201360.","journal-title":"Am J Hematol"},{"key":"14_CR19","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0925-5710(97)00039-X","volume":"66","author":"T Iwasaki","year":"1997","unstructured":"Iwasaki T, Hamano T, Kobayashi K, Kakishita E: A case of mu-heavy chain disease: combined features of mu-chain disease and macroglobulinemia. Int J Hematol 1997, 66:359\u2013365.","journal-title":"Int J Hematol"},{"key":"14_CR20","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s002770050448","volume":"77","author":"M Witzens","year":"1998","unstructured":"Witzens M, Egerer G, Stahl D, et al.: A case of mu heavy-chain disease associated with hyperglobulinemia, anemia, and a positive Coombs test. Ann Hematol 1998, 77:231\u2013234.","journal-title":"Ann Hematol"},{"key":"14_CR21","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0046-8177(84)80051-9","volume":"15","author":"RP Tracy","year":"1984","unstructured":"Tracy RP, Kyle RA, Young DS, et al.: Two-dimensional gel electrophoresis as an aid in the analysis of monoclonal gammopathies. Hum Pathol 1984, 15:122\u2013129.","journal-title":"Hum Pathol"},{"key":"14_CR22","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/clinchem\/27.2.331","volume":"27","author":"DS O\u2019Reilly","year":"1981","unstructured":"O\u2019Reilly DS, Adjukiewicz A, Whicher JT: Biochemical findings in a case of mu-chain disease. Clin Chem 1981, 27:331\u2013333.","journal-title":"Clin Chem"},{"key":"14_CR23","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0025-6196(12)65225-2","volume":"62","author":"RA Kyle","year":"1987","unstructured":"Kyle RA, Garton JP: The spectrum of IgM monoclonal gammopathy in 430 cases. Mayo Clin Proc 1987, 62:719\u2013731.","journal-title":"Mayo Clin Proc"},{"key":"14_CR24","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1046\/j.1365-2141.2000.01918.x","volume":"108","author":"RA Kyle","year":"2000","unstructured":"Kyle RA, Greipp PR, Gertz MA, et al.: Waldenstrom\u2019s macroglobulinaemia: a prospective study comparing daily with intermittent oral chlorambucil. Br J Haematol 2000, 108:737\u2013742.","journal-title":"Br J Haematol"},{"key":"14_CR25","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/00004836-199807000-00020","volume":"27","author":"A Zamir","year":"1998","unstructured":"Zamir A, Parasher G, Moukarzel AA, et al.: Immunoproliferative small intestinal disease in a 16-year-old boy presenting as severe malabsorption with excellent response to tetracycline treatment. J Clin Gastroenterol 1998, 27:85\u201389.","journal-title":"J Clin Gastroenterol"},{"key":"14_CR26","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/bjs.1800810107","volume":"81","author":"IG Martin","year":"1994","unstructured":"Martin IG, Aldoori MI: Immunoproliferative small intestinal disease: Mediterranean lymphoma and alpha heavy chain disease. Br J Surg 1994, 81:20\u201324.","journal-title":"Br J Surg"},{"key":"14_CR27","first-page":"207","volume":"2","author":"A Khojasteh","year":"1983","unstructured":"Khojasteh A, Saalabian M, Haghshenass M: Randomized comparison of abdominal irradiation (AI) vs CHOP vs C-MOPP for the treatment of immunoproliferative small intestinal disease (IPSID) associated lymphoma. Proc ASCO 1983, 2:207.","journal-title":"Proc ASCO"},{"key":"14_CR28","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/00000421-199602000-00004","volume":"19","author":"M Salimi","year":"1996","unstructured":"Salimi M, Spinelli JJ: Chemotherapy of Mediterranean abdominal lymphoma: retrospective comparison of chemotherapy protocols in Iranian patients. Am J Clin Oncol 1996, 19:18\u201322.","journal-title":"Am J Clin Oncol"},{"key":"14_CR29","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1002\/1097-0142(19890401)63:7<1251::AID-CNCR2820630704>3.0.CO;2-H","volume":"63","author":"F Ben-Ayed","year":"1989","unstructured":"Ben-Ayed F, Halphen M, Najjar T, et al.: Treatment of alpha chain disease: results of a prospective study in 21 Tunisian patients by the Tunisian-French intestinal Lymphoma Study Group. Cancer 1989, 63:1251\u20131256.","journal-title":"Cancer"},{"key":"14_CR30","first-page":"209","volume":"33","author":"R Hubmann","year":"1995","unstructured":"Hubmann R, Kaiser W, Radaszkiewicz T, et al.: Malabsorption associated with a high-grade-malignant non-Hodgkin\u2019s lymphoma, alpha-heavy-chain disease and immunoproliferative small intestinal disease. Z Gastroenterol 1995, 33:209\u2013213.","journal-title":"Z Gastroenterol"},{"key":"14_CR31","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/(SICI)1097-0142(19970701)80:1<8::AID-CNCR2>3.0.CO;2-T","volume":"80","author":"H Akbulut","year":"1997","unstructured":"Akbulut H, Soykan I, Yakaryilmaz F, et al.: Five-year results of the treatment of 23 patients with immunoproliferative small intestinal disease: a Turkish experience. Cancer 1997, 80:8\u201314.","journal-title":"Cancer"},{"key":"14_CR32","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1365-2559.1990.tb00658.x","volume":"17","author":"SK Price","year":"1990","unstructured":"Price SK: Immunoproliferative small intestinal disease: a study of 13 cases with alpha heavy-chain disease. Histopathology 1990, 17:7\u201317.","journal-title":"Histopathology"},{"key":"14_CR33","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1200\/JCO.1994.12.7.1375","volume":"12","author":"LY Shih","year":"1994","unstructured":"Shih LY, Liaw SJ, Dunn P, Kuo TT: Primary smallintestinal lymphomas in Taiwan: immunoproliferative small-intestinal disease and nonimmunoproliferative small-intestinal disease. J Clin Oncol 1994, 12:1375\u20131382.","journal-title":"J Clin Oncol"},{"key":"14_CR34","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/mpo.2950250507","volume":"25","author":"IA Malik","year":"1995","unstructured":"Malik IA, Shamsi Z, Shafquat A, et al.: Clinicopathological features and management of immunoproliferative small intestinal disease and primary small intestinal lymphoma in Pakistan. Med Pediatr Oncol 1995, 25:400\u2013406.","journal-title":"Med Pediatr Oncol"},{"key":"14_CR35","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/0002-9343(90)90380-V","volume":"89","author":"A Khojasteh","year":"1990","unstructured":"Khojasteh A, Haghighi P, Rabhi H, et al.: Immunoproliferative small intestinal disease: portrait of a potentially preventable cancer from the Third World. Am J Med 1990, 89:483\u2013490.","journal-title":"Am J Med"},{"key":"14_CR36","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1200\/JCO.1998.16.8.2825","volume":"16","author":"P McLaughlin","year":"1998","unstructured":"McLaughlin P, Grillo-Lopez AJ, Link BK, et al.: Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program. J Clin Oncol 1998, 16:2825\u20132833.","journal-title":"J Clin Oncol"}],"container-title":["Current Treatment Options in Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-002-0014-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11864-002-0014-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-002-0014-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,23]],"date-time":"2020-04-23T19:17:03Z","timestamp":1587669423000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11864-002-0014-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,6]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2002,6]]}},"alternative-id":["14"],"URL":"https:\/\/doi.org\/10.1007\/s11864-002-0014-3","relation":{},"ISSN":["1527-2729","1534-6277"],"issn-type":[{"value":"1527-2729","type":"print"},{"value":"1534-6277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,6]]}}}